Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 8 min ago
PreprintCC BYbioRxiv

Novel 3D Mature Osteocyte Perfusion Platform Reveals Subtype-Dependent and Radiation-Sensitive Disruption of Mechanotransduction by Breast Cancer Secretomes

Abstract

Osteocytes (OCys) coordinate bone remodeling by transducing mechanical signals into anabolic cues, primarily through suppressing sclerostin and RANKL. In breast cancer (BCa) bone metastasis, mechanical loading fails to restore lost bone, pointing to tumor-induced OCy mechanosensory dysfunction. Here, we investigate how BCa molecular subtype heterogeneity and frontline therapies like radiation influence OCy mechanobiology. We leveraged a 3D mineralized scaffold paired with a forced perfusion bioreactor to establish a physiologically relevant model of mature, dendrite-bearing OCys. After optimizing perfusion parameters, 3D mature OCys were exposed to conditioned media (CM) from estrogen receptor-positive (ER+; ZR-75-1) or triple-negative (TN; MDA-MB-231) BCa cells generated 24 h post-irradiation (0 vs. 2 Gy). Downstream OCy gene expression (Sost, Tnfsf11, Tnfrsf11b) and tumor CM proteomic profiles (84 oncology targets) were evaluated. Differentiated 3D MPC-2s exhibited interconnected dendritic networks, classical responsiveness to parathyroid hormone, and robust flow-induced Sost suppression. Non-irradiated ER+ BCa CM preserved canonical OCy mechanoresponsiveness (Sost downregulation post-flow), but this response was eliminated when ER+ cells received 2 Gy radiation. Conversely, TN CM blunted flow-induced Sost suppression regardless of irradiation status. Proteomic profiling revealed that BCa subtype was the primary driver of secretome composition, whereas 2 Gy radiation induced distinct directional secretome shifts between subtypes. These findings demonstrate that BCa-induced impairment of OCy mechanosensing is subtype-dependent and that low-dose radiation further exacerbates secretome-mediated mechanosensory loss in ER+ disease, highlighting key tumor-derived targets for restoring skeletal health.

Related

  1. Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway
    Margaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati +11
    OncogenesisPeer-reviewedCC BY 4.0Full text2 citedCell biologyHAL
  2. Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer
    Frédéric Fercoq, Gemma Cairns, Victoria Bridgeman +22
    Cell ReportsPeer-reviewedCC BY6 citedImmunologyHAL
  3. Sex-dependent disruption of affective behaviors by GBR 12909: relevance to bipolar disorders
    Maelle Certon, Bruno Brizard, Catherine Belzung +3
    NeuropharmacologyPeer-reviewedCC BY 4.0Full textNeurosciencePsychiatry & mental healthHAL
  4. Dosage-dependent disruption of corticofugal neuron development by Fezf2 loss
    M. J. Hossain, S. N. I. Abhi, M. M. Islam +3
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  5. Bone Response to Mechanical Loading is Highly Heritable and Correlates with Osteocyte Lacunar Morphology in Genetically Diverse Mouse Strains
    N. Migotsky, S. Lamia, J. T. Shuster +3
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
BibTeX
@misc{salcidoalcantar2026novel,
  title = {{Novel 3D Mature Osteocyte Perfusion Platform Reveals Subtype-Dependent and Radiation-Sensitive Disruption of Mechanotransduction by Breast Cancer Secretomes}},
  author = {Antonio Salcido-Alcántar and Corrin Bowman and Ellie Goldman and Emma N Briggs and Anthony M Bierschenk and Tanvi K Rami and William R Thompson and Maureen E Lynch},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.22.760275},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.22.760275v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Novel 3D Mature Osteocyte Perfusion Platform Reveals Subtype-Dependent and Radiation-Sensitive Disruption of Mechanotransduction by Breast Cancer Secretomes
AU  - Antonio Salcido-Alcántar
AU  - Corrin Bowman
AU  - Ellie Goldman
AU  - Emma N Briggs
AU  - Anthony M Bierschenk
AU  - Tanvi K Rami
AU  - William R Thompson
AU  - Maureen E Lynch
PY  - 2026
DA  - 2026/10/22
PB  - bioRxiv
DO  - 10.64898/2026.10.22.760275
UR  - https://www.biorxiv.org/content/10.64898/2026.10.22.760275v1
AB  - Osteocytes (OCys) coordinate bone remodeling by transducing mechanical signals into anabolic cues, primarily through suppressing sclerostin and RANKL. In breast cancer (BCa) bone metastasis, mechanical loading fails to restore lost bone, pointing to tumor-induced OCy mechanosensory dysfunction. Here, we investigate how BCa molecular subtype heterogeneity and frontline therapies like radiation influence OCy mechanobiology. We leveraged a 3D mineralized scaffold paired with a forced perfusion bioreactor to establish a physiologically relevant model of mature, dendrite-bearing OCys. After optimizing perfusion parameters, 3D mature OCys were exposed to conditioned media (CM) from estrogen receptor-positive (ER+; ZR-75-1) or triple-negative (TN; MDA-MB-231) BCa cells generated 24 h post-irradiation (0 vs. 2 Gy). Downstream OCy gene expression (Sost, Tnfsf11, Tnfrsf11b) and tumor CM proteomic profiles (84 oncology targets) were evaluated. Differentiated 3D MPC-2s exhibited interconnected dendritic networks, classical responsiveness to parathyroid hormone, and robust flow-induced Sost suppression. Non-irradiated ER+ BCa CM preserved canonical OCy mechanoresponsiveness (Sost downregulation post-flow), but this response was eliminated when ER+ cells received 2 Gy radiation. Conversely, TN CM blunted flow-induced Sost suppression regardless of irradiation status. Proteomic profiling revealed that BCa subtype was the primary driver of secretome composition, whereas 2 Gy radiation induced distinct directional secretome shifts between subtypes. These findings demonstrate that BCa-induced impairment of OCy mechanosensing is subtype-dependent and that low-dose radiation further exacerbates secretome-mediated mechanosensory loss in ER+ disease, highlighting key tumor-derived targets for restoring skeletal health.
SN  - 2692-8205
ER  -